新洁而灭对海洋原甲藻赤潮生物的灭杀与抑制

研究了十二烷基二甲基卞基溴化铵(新洁而灭)和戊二醛对赤潮生物的灭杀和控制作用。结果表明，新洁而灭可以有效地杀灭海洋原甲藻，浓度0．10mg/L时，可以控制海洋原甲藻的增长，浓度大于0．15mg/L时，除藻率可达到90％以上。戊二醛也具有除藻效果，但作用浓度较高，浓度大于3．0mg/L，除藻率可达到50％以上。戊二醛与新洁而灭复配时具有协同作用，可提高除藻能力。当戊二醛与新洁而灭配比为10：1时，协同指数小于1，协同作用比较明显，戊二醛与新洁而灭可复配使用。     

流式细胞计分析海洋微微型浮游生物:样品固定及贮存方法

以流式细胞计为海洋微微型浮游生物的分析工具,研究了醛类固定剂的固定、液氮贮存对于微微型浮游生物的细胞大小、密度、藻红素荧光值(FL2)和叶绿素荧光值(FL3)的影响.实验主要结论为1)液氮环境适于贮存固定的微微型浮游生物样品,而未固定样品在液氮中贮存后细胞密度有损失;2)醛类固定剂对微微型浮游生物样品的细胞密度基本没有影响;3)醛类固定剂可增强微微型浮游生物的荧光强度,其中戊二醛主要影响聚球藻的FL2强度,多聚甲醛主要影响FL3强度.认为多聚甲醛是适用于微微型浮游生物的固定剂,推荐使用浓度为0.8%~1.2%,此外戊二醛浓度为0.05%、多聚甲醛浓度为0.8%~1.2%的混合固定剂亦适用于固定微微型浮游生物.图4参15     

Abatement of sulfide generation in sewage by glutaraldehyde supplementation and the impact on the activated sludge accordingly

Hydrogen sulfide emission in sewer systems is associated with toxicity, corrosion, odour nuisance and high costs treatment. In this study, a novel method to inhibit sulfide generation from sewage by means of glutaraldehyde supplementation has been suggested and evaluated under anaerobic conditions. Different concentrations of glutaraldehyde at 10, 15, 20, 30 and 40 mg·L^-1 have been investigated. Besides, the possible impacts of glutaraldehyde supplementation on an activated sludge system and an appraisal of the economic aspects are presented as well. As observed from the experimental results, a dosage of 20 mg·L^-1 glutaraldehyde resulted in a significant decrease of the sulfide production by 70%–80% in the simulated sewage. Moreover, the impacts of additional glutaraldehyde at 20 mg·L^-1 on activated sludge, in terms of chemical oxygen demand removal and oxygen uptake rates, were negligible. From an economical point of view, the cost of the commercial glutaraldehyde products required in the operation, which was calculated on the basis of activated sulfide removal avoidance, was around €3.7–4.6 S·kg^-1. Therefore it is suggested that glutaraldehyde supplementation is a feasible technique to abate the sulfide problems in sewer systems. Yet further research is required to elucidate the optimum “booster” dosage and the dosing frequency in situ accordingly.